StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly (LLY) PT Raised to $180 at BofA Securities
June 19, 2020 9:25 AM
BofA Securities analyst Jason Gerberry raised the price target on Eli Lilly (NYSE: LLY) to $180.00 (from $165.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst PT Change
Next Articles
ELAN Class Action Deadline: Barbuto & Johansson, P.A. Reminds Elanco Animal Health, Inc. Shareholders of Important Deadline in the Recently Filed Securities Class Action
June 18, 2020 2:30 PM
Eli Lilly (LLY) PT Raised to $180 at Cowen
June 18, 2020 9:52 AM
Eli Lilly & Co. (LLY) Initiates Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients
June 18, 2020 8:05 AM
Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients
June 18, 2020 8:00 AM
Eli Lilly & Co. (LLY) Announces Emgality Demonstrates Reduction in Frequency, Duration, and Pain Severity in Patients with Episodic and Chronic Migraine
June 17, 2020 6:46 AM
Emgality® Demonstrates Reduction in Frequency, Duration, and Pain Severity in Patients with Episodic and Chronic Migraine
June 17, 2020 6:45 AM
Eli Lilly (LLY) PT Raised to $166 at UBS
June 17, 2020 5:39 AM
